Litcius/Paper detail

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?

Mari Amino, Tomokazu Fukushima, Atsushi Uehata, Chiemi Nishikawa, Seiji Morita, Yoshihide Nakagawa, Tsutomu Murakami, Koichiro Yoshioka, Yuji Ikari

2021Annals of Noninvasive Electrocardiology10 citationsDOIOpen Access PDF

Abstract

A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock was repeated until glucagon administration was initiated. Second, he developed acute coronary syndrome. Two mechanisms contributing to Kounis syndrome were differentiated: 1) adrenaline induced coronary spasm and platelet activation or 2) a mismatch between oxygen supply and demand due to an allergic reaction. Beta-blocker therapy was discontinued because his cardiac function was preserved. Secondary preventive beta-blockers in recovering myocardial infarction with severe anaphylaxis history should be carefully considered.

Topics & Concepts

MedicineKounis syndromeAnaphylaxisMyocardial infarctionCardiogenic shockCardiologyInternal medicineBeta blockerShock (circulatory)CarvedilolBETA (programming language)Anaphylactic shockAcute coronary syndromeAnesthesiaAllergyHeart failureImmunologyProgramming languageComputer scienceFood Allergy and Anaphylaxis ResearchViral Infections and Immunology ResearchDrug-Induced Adverse Reactions
Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome? | Litcius